Stock Events

Stock Events

Atrium Therapeutics (RNA) Q2 2024 Earnings

9MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.8

-0.75

-0.71

-0.66

Details

Expected EPS

-0.796129

Actual EPS

-0.79

Surprise EPS

0.01

Surprise Percent

+0.77%

Description

Atrium Therapeutics (RNA) has reported earnings of -0.79 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.